Martin Mackay
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Martin Mackay
Martin Mackay is recorded as Chairman at Charles River Laboratories International, Inc. (CRL). Charles River Laboratories International, Inc. reported in an 8-K filed January 9, 2026 that Martin Mackay was appointed Chair of the Board, effective May 5, 2026.
“Dr. Martin Mackay, current Lead Independent Director, is expected to become Chair of the Board, effective as of the Transition Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Charles River Laboratories International, Inc.
Other people whose current roles at this company are on record from its filings.
- Abraham Ceesay CEO, Board Member
- Craig B. Thompson CEO, Board Member
- James C. Foster CEO, Board Member
- James Foster CEO, Board Member
- Mark Enyedy CEO, Board Member
- Martin W. Mackay CEO, Board Member
- Paul Graves CEO, Board Member
- Reshema Kemps-Polanco CEO, Board Member
- George M. Milne Chairman
- Michael G. Knell CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.